Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato

Showing results (771-780 of 4,414) with videos related to

Pageof 442
Sort By:
Reproductive Sciences (Thousand Oaks, Calif.)|April 25, 2012
Maternal micronutrient status and preterm versus term birth for black and white US womenAnne L Dunlop, Robert N Taylor, Vin Tangpricha, et al.
Current Pharmaceutical Design|November 30, 2007
Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signalingRoberto Bianco, Vincenzo Damiano, Teresa Gelardi, et al.
Fertility and Sterility|February 1, 1994
A morphological and functional study of fusibility in round-headed spermatozoa in the humanB Dale, M Iaccarino, A Fortunato, et al.
European Urology|January 1, 1996
Transurethral electrovaporization of the prostate with the Vaportrode VE-B. Preliminary resultsM Gallucci, P Puppo, P Fortunato, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapyBarbara Frederick, Dan Gustafson, Cataldo Bianco, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 27, 2015
Distinct neurohumoral biomarker profiles in children with hemodynamically defined orthostatic intolerance may predict treatment optionsAshley L Wagoner, Hossam A Shaltout, John E Fortunato, et al.
Sensors (Basel, Switzerland)|December 4, 2015
Simulated and Real Sheet-of-Light 3D Object Scanning Using a-Si:H Thin Film PSD ArraysJavier Contreras, Josep Tornero, Isabel Ferreira, et al.
Biosensors & Bioelectronics|July 5, 2016
8-hydroxy-2'-deoxyguanosine (8-OHdG) biomarker detection down to picoMolar level on a plastic antibody filmGabriela V Martins, Ana C Marques, Elvira Fortunato, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|February 8, 2018
Visualising numerals: An ERPs study with the attentional SNARC taskMario Pinto, Enrico Fattorini, Stefano Lasaponara, et al.
Clinical Lung Cancer|July 25, 2008
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trialCesare Gridelli, Charles Butts, Fortunato Ciardiello, et al.
Pageof 442

Showing results (771-780 of 4,414) with videos related to

Sort By:
Pageof 442
Reproductive Sciences (Thousand Oaks, Calif.)|April 25, 2012
Maternal micronutrient status and preterm versus term birth for black and white US womenAnne L Dunlop, Robert N Taylor, Vin Tangpricha, et al.
Current Pharmaceutical Design|November 30, 2007
Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signalingRoberto Bianco, Vincenzo Damiano, Teresa Gelardi, et al.
Fertility and Sterility|February 1, 1994
A morphological and functional study of fusibility in round-headed spermatozoa in the humanB Dale, M Iaccarino, A Fortunato, et al.
European Urology|January 1, 1996
Transurethral electrovaporization of the prostate with the Vaportrode VE-B. Preliminary resultsM Gallucci, P Puppo, P Fortunato, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapyBarbara Frederick, Dan Gustafson, Cataldo Bianco, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 27, 2015
Distinct neurohumoral biomarker profiles in children with hemodynamically defined orthostatic intolerance may predict treatment optionsAshley L Wagoner, Hossam A Shaltout, John E Fortunato, et al.
Sensors (Basel, Switzerland)|December 4, 2015
Simulated and Real Sheet-of-Light 3D Object Scanning Using a-Si:H Thin Film PSD ArraysJavier Contreras, Josep Tornero, Isabel Ferreira, et al.
Biosensors & Bioelectronics|July 5, 2016
8-hydroxy-2'-deoxyguanosine (8-OHdG) biomarker detection down to picoMolar level on a plastic antibody filmGabriela V Martins, Ana C Marques, Elvira Fortunato, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|February 8, 2018
Visualising numerals: An ERPs study with the attentional SNARC taskMario Pinto, Enrico Fattorini, Stefano Lasaponara, et al.
Clinical Lung Cancer|July 25, 2008
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trialCesare Gridelli, Charles Butts, Fortunato Ciardiello, et al.
Pageof 442